Literature DB >> 35099257

Absence of a significant interaction of two common NOS1 and 5-HTT polymorphisms on sensorimotor gating in humans.

R Rovný1, M Marko, G Minárik, I Riečanský.   

Abstract

The neurotransmitter serotonin has been critically implicated in the pathogenesis of several mental disorders. The serotonin transporter (5-HTT) is a key regulator of serotonergic neurotransmission and its genetic variability is associated with increased risk of psychopathology. One well known polymorphic locus in the 5-HTT gene affecting its expression is a tandem repeat in the promoter region (5-HTTLPR). It has been reported that 5-HTT is functionally coupled with the neuronal nitric oxide synthase (NOS1 or nNOS), an enzyme catalyzing the production of nitric oxide (NO). We have previously demonstrated that a tandem repeat polymorphism in the promoter of NOS1 exon 1f (Ex1f-VNTR) is associated with sensorimotor gating, a marker of inhibitory processing and a well established endophenotype of several neuropsychiatric disorders. Here we investigated the combined genetic effects of NOS1 Ex1f-VNTR and 5-HTTLPR on sensorimotor gating, measured by prepulse inhibition (PPI) of the acoustic startle reflex, in 164 healthy adults. We found no evidence for the interaction between NOS1 Ex1f-VNTR and 5-HTTLPR on PPI. PPI was associated with NOS1 Ex1f-VNTR, but not 5-HTTLPR. Our data suggest that while NOS1 plays a role in sensorimotor gating, the nitrergic pathway of gating regulation does not involve the action of 5-HTT.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 35099257      PMCID: PMC8884391          DOI: 10.33549/physiolres.934819

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  43 in total

1.  Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers.

Authors:  V Kumari; S A Checkley; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1996-11       Impact factor: 4.530

2.  Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.

Authors:  G Maura; M Marcoli; O Pepicelli; C Rosu; C Viola; M Raiteri
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants.

Authors:  M Nakamura; S Ueno; A Sano; H Tanabe
Journal:  Mol Psychiatry       Date:  2000-01       Impact factor: 15.992

Review 4.  Human and animal studies of schizophrenia-related gating deficits.

Authors:  G A Light; D L Braff
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 5.  A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders.

Authors:  M Anguelova; C Benkelfat; G Turecki
Journal:  Mol Psychiatry       Date:  2003-06       Impact factor: 15.992

6.  Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin.

Authors:  M E Liechti; M A Geyer; D Hell; F X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2001-03       Impact factor: 7.853

7.  Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.

Authors:  Pablo R Moya; Jens R Wendland; Liza M Rubenstein; Kiara R Timpano; Gary A Heiman; Jay A Tischfield; Robert A King; Anne M Andrews; Samanda Ramamoorthy; Francis J McMahon; Dennis L Murphy
Journal:  Mov Disord       Date:  2013-04-29       Impact factor: 10.338

8.  The 5-HTTLPR polymorphism and posttraumatic stress disorder: a meta-analysis.

Authors:  Florence Gressier; Raffaella Calati; Martina Balestri; Agnese Marsano; Siegfried Alberti; Niki Antypa; Alessandro Serretti
Journal:  J Trauma Stress       Date:  2013-11-12

9.  Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase.

Authors:  S Chiavegatto; V L Dawson; L A Mamounas; V E Koliatsos; T M Dawson; R J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.